Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells

874Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The hormone-dependent human breast cancer cell line MCF-7 secretes transforming growth factor-β (TGF-β), which can be detected in the culture medium in a biologically active form. These polypeptides compete with human platelet-derived TGF-β for binding to its receptor, are biologically active in TGF-β-specific growth assays, and are recognized and inactivated by TGF-β-specific antibodies. Secretion of active TGF-β is induced 8 to 27-fold under treatment of MCF-7 cells with growth inhibitory concentrations of antiestrogens. Antiestrogen-induced TGF-β from MCF-7 cells inhibits the growth of an estrogen receptor-negative human breast cancer cell line in coculture experiments; growth inhibition is reversed with anti-TGF-β antibodies. We conclude that in MCF-7 cells, TGF-β is a hormonally regulated growth inhibitor with possible autocrine and paracrine functions in breast cancer cells. © 1987.

Cite

CITATION STYLE

APA

Knabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasid, A., Derynck, R., & Dickson, R. B. (1987). Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48(3), 417–428. https://doi.org/10.1016/0092-8674(87)90193-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free